Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GRIA4 | P48058 | 8/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 7/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 7/20 | 0.34 |
| ▸ | GRIA3 | P42263 | 7/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.34 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.34 |
| ▸ | GRIK4 | Q16099 | 3/20 | 0.34 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.34 |
| ▸ | ALPI | P09923 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | XIAP | P98170 | 1/20 | 0.32 |
| ▸ | CIT | O14578 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL6801013 | 1.00 | SLC7A5 (0.36) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL183768 | 0.92 | SLC7A5 (0.38) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL183769 | 0.92 | SLC7A5 (0.38) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL14940945 | 0.92 | SLC7A5 (0.38) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL2024731 | 0.89 | SLC7A5 (0.37) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL6803051 | 0.88 | SLC7A5 (0.38) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL6803056 | 0.88 | SLC7A5 (0.38) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL1528035 | 0.88 | SLC7A5 (0.35) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL1528037 | 0.88 | SLC7A5 (0.35) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 | |
| Histidine SCHEMBL27580772 | 0.88 | SLC7A5 (0.35) | SLC7A5CYP3A4CYP1A2GRIA4GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1358485-A2 | METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING VASOACTIVE INTESTINAL PEPTIDE RECEPTORS | THE PROCTER & GAMBLE COMPANY (US) | 2003-11-05 | — | — | EP | claimed |
| WO-2002035240-A2 | METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING VASOACTIVE INTESTINAL PEPTIDE RECEPTORS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-02 | — | — | WO | claimed |
| US-20040176298-A1 | Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-09 | — | — | US | disclosed |
| US-6750194-B1 | ADMINISTERING TO THE SUBJECT A SAFE AND EFFECTIVE AMOUNT OF A VPAC RECEPTOR AGONIST SELECTED FROM THE GROUP CONSISTING OF RO 25-1553, AND PACAP-38 | THE PROCTER & GAMBLE COMPANY | 2004-06-15 | — | — | US | disclosed |
| EP-1358485-A2 | METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING VASOACTIVE INTESTINAL PEPTIDE RECEPTORS | THE PROCTER & GAMBLE COMPANY (US) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002035240-A2 | METHODS FOR IDENTIFYING COMPOUNDS FOR REGULATING MUSCLE MASS OR FUNCTION USING VASOACTIVE INTESTINAL PEPTIDE RECEPTORS | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-02 | — | — | WO | disclosed |
| EP-1068347-A1 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | Millennium Pharmaceuticals, Inc. (US) | 2001-01-17 | — | — | EP | disclosed |
| WO-1999051762-A9 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | MILLENNIUM PHARM INC (US) | 2000-05-25 | — | — | WO | disclosed |
| WO-1999051762-A1 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-10-14 | — | — | WO | disclosed |
| US-5217953-A | Administering polypeptide to mammals to inhibit vip effect on sexual behavior and the growth of lung cancer cells | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1993-06-08 | — | — | US | disclosed |